CMPX Compass Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

CMPX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CMPX
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

CMPX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CMPX
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

CMPX is expected to report earnings to rise 10.00% to -10 cents per share on November 07

Compass Therapeutics CMPX Stock Earnings Reports

Q3'24

Est.

$-0.11

Q2'24

Est.

$-0.10

Q1'24

Beat

by $0.03

Q4'23

Missed

by $0.02

Q3'23

Beat

by $0.03

The last earnings report on August 12 showed earnings per share of -10 cents, meeting the estimate of -10 cents. With 300.87K shares outstanding, the current market capitalization sits at 258.67M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

80 Guest Street

Phone

+1 617 500-8099

Employees

Web

https://www.compasstherapeutics.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	23.14	-0.28	-1.20%
GameStop Corp
TSLA	210.60	-3.51	-1.64%
Tesla
SPY	552.08	-11.60	-2.06%
SPDR® S&P 500® ETF Trust
AAPL	222.77	-6.23	-2.72%
Apple
BTC.X	57431.023000	-1681.457000	-2.84%
Bitcoin cryptocurrency

CMPX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with ABCL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then ABCL could also see price increases.

Ticker / NAME	Correlation To CMPX	1D Price Change %
CMPX	100%	-4.43%
ABCL - CMPX	43% Loosely correlated	-2.34%
KOD - CMPX	41% Loosely correlated	-3.59%
XNCR - CMPX	40% Loosely correlated	-3.14%
NTLA - CMPX	39% Loosely correlated	-3.65%
SEER - CMPX	38% Loosely correlated	-0.60%
More